We investigated the effect of adrenergic receptor stimulation or inhibition on the hepatic ultrastructural changes in a porcine faecal peritonitis model of multi-organ failure. We infused either the α 1 adrenergic receptor agonist methoxamine or the β 2 adrenergic receptor antagonist ICI 118551 during 8 h of the study.
INTRODUCTION
The high morbidity and mortality of patients with septicaemia and end-organ dysfunction has defied successful intervention and therapy. In critically ill patients, well-designed randomized prospective trials of agents and morphometric analysis of ultrastructural changes to quantify and compare these changes. We have recently reported [5] the important contrasting changes in liver ultrastructure in this animal model when either dopexamine or dobutamine is infused. We considered that the differing pharmacology of these two agents was associated with their dissimilar effect on hepatic ultrastructure during sepsis. The pharmacology of dopexamine is reasonably well established [6, 7] ; it is a β # adrenergic receptor agonist with dopamine 1 and 2 properties. The pharmacology of dobutamine is not quite so clear cut ; the prime literature describes it as a racemic mixture [8] [9] [10] . The (k)-enantiomer of dobutamine is predominantly an α1 adrenergic receptor agonist which has been shown to display greater inotropic selectivity than the (j)-enantiomer, which is predominantly a β " and β # adrenergic receptor agonist. The drug's inotropic effect appears to be mediated primarily through α " adrenergic receptor stimulation which increases cardiac output by stimulation of cardiac α adrenergic receptors [11] , but its pressor effect is offset by dilation of blood vessels induced by β # adrenergic receptor stimulation. In this animal model of hepatic damage during sepsis the changes are well documented [4, 5] ; we have described sinusoidal leucostasis and activation of sinusoidal leucocytes with endothelial and Kupffer cell swelling, which result in occlusion of the sinusoidal lumen. Although there is deterioration of hepatocyte mitochondria and dilation of endoplasmic reticulum there are rarely any other major changes to hepatocytes or dilation of the Space of Disse.
In an earlier study we reported [5] how further major deterioration was observed in the liver when dobutamine was infused during sepsis. The endothelium became detached from the hepatocyte apical membrane, many apical membranes were disrupted spilling out their cell contents, and hepatocytes became detached from each other allowing blood cells to circulate among them. In addition, a considerable number of membrane-lined vacuoles were observed in the hepatocytes. This deterioration was observed when hepatic blood flow was maintained above basal levels, discounting the possibility that further hepatic injury might have been due to ischaemia or inappropriate distribution of blood flow.
When dopexamine was infused in this septic animal model there was a reduction in hepatic ultrastructural deterioration reflected by a significant reduction in sinusoidal leucostasis, endothelial and Kupffer cell swelling and sinusoidal occlusion. There was no dilation of the Space of Disse and no vacuolation of hepatocytes.
The difference between these two agents lies in dobutamine being an α " adrenergic receptor agonist. There are no previous reports of α adrenergic receptor agonists inducing additional injury in septic animals when normal blood flow is maintained. Minneman [12] described how inflammatory mediators such as thrombin, histamine, leukotrienes and bradykinin, and the α " adrenergic receptor agonists, although stimulating their own cell surface receptor, all elicit a cellular response by activating the same trimeric G-protein complex to activate the transmitter Gq. Gq activation initiates the inflammatory process by the production of both inflammatory lipids and peptides.
Competitive binding studies [13] using β " and β # adrenergic receptor antagonists showed both adrenergic receptors to be present on the endothelium ; 89 % were β # receptors and 11 % β " receptors. The anti-inflammatory effect of isoproterenol is via the β # receptor alone. It is well established that β # adrenergic receptor agonists reduce the inflammatory response in sepsis, endotoxin and reperfusion injury in animal models. We have recently reviewed [14] much of the work describing the anti-inflammatory effect of β # adrenergic receptor agonists. We described the reduction in both capillary permeability and the production of inflammatory mediators in monolayer preparations of endothelium, isolated organs and whole animals to inflammatory stimulation. We suggested that in endothelial cells, when the second messenger cytosolic cAMP is raised, an endogenous anti-inflammatory response is initiated, but inhibition of this endogenous response could cause an amplification of the inflammatory response.
We hypothesized that stimulation of α " adrenergic receptors or inhibition of β # adrenergic receptors in this animal model is very likely to amplify the inflammatory response to sepsis and result in additional hepatic injury. Such a finding would be novel and could change our understanding of the mechanism of the inflammatory response and the action of adrenergic receptor agonists, especially when given during a major inflammatory response.
Methoxamine is a specific α " adrenergic receptor agonist with no record of tissue injury when normal blood flow is maintained. The specific β # adrenergic receptor antagonist ICI 118551 has been used extensively in animal studies [15, 16] and β adrenergic receptor antagonists (e.g. propranolol) are used extensively in clinical practice ; neither have a record of tissue injury.
To provide data for our hypothesis we infused these two agents in our established septic porcine model of hepatic injury for 8 h, measuring cardiac output and portal blood flow. Portal blood flow was measured as an index of hepatic blood flow. We have previously measured both portal blood flow and hepatic artery blood flow to calculate total blood flow. Our experience has shown that hepatic artery measurement is unnecessary, as increasing total blood flow does not provide hepatic protection during sepsis in this animal model. In pigs, hepatic artery blood flow accounts for about 15 % of total flow ; if hepatic artery blood flow reduces there is usually a compensatory increase from the portal vein to maintain total hepatic blood flow. Our previous study [5] shows that total hepatic blood flow is primarily dependent on cardiac output.
In the non-septic methoxamine group cardiac output and portal blood flow were also measured to prevent a fall in these parameters. Surgical interventions such as a laparotomy have known associations with major changes in leucocyte function. Experience of this surgical procedure combined with gut manipulation when inserting flow probes stimulate a considerable increase in peritoneal fluid leak requiring fluid infusion to maintain baseline parameters. We avoid this intervention when studying control animals. An infusion of ICI 118551 is not associated with major vasoactive effects so it was unnecessary to perform a laparotomy in the non-septic group treated with ICI 118551. We also studied two noninfected groups : a control group with minimal intervention for normal histology and a non-septic group with similar criteria to the non-septic ICI 118551 group.
Morphometric analysis was performed on hepatic tissue removed from these animals after 8 h of sepsis. The evidence provided by this study supports the hypothesis that α " adrenergic receptor agonists are pro-inflammatory only during the septic response. Inhibition of β # adrenergic receptors potentiates the inflammatory response to sepsis and amplifies hepatic ultrastructural damage.
METHOD
The study was authorized by the U.K. Secretary of State under the provisions of the 1986 Animals (Scientific Procedures) Act. The number of pigs in each group was kept to a minimum because of the high cost involved in large animal studies and the unnecessary use of animals in medical research, in line with current thoughts on animal welfare. Anaesthesia was induced with azaperone (2.0 mg\kg intramuscularly) and metomidate (10 mg\kg intraperitoneally) in 31 Middle White adolescent pigs weighing 25-30 kg. Sterile conditions were maintained throughout the study in all groups. The pigs were placed on the operating table and a face mask used to administer oxygen, nitrous oxide and isoflurane. A tracheotomy was performed to maintain anaesthesia during the surgical procedure and multi-bore catheters were inserted into the internal jugular vein for fluid and drug infusion. A single-lumen catheter was inserted into the ear vein for later anaesthetic administration. The study protocol is shown in Table 1 .
Eleven of these animals had no more surgical interventions performed and were divided into three groups for control hepatic histology. Five of these animals (control group) had hepatic tissue removed and were then culled to demonstrate normal hepatic tissue. Three animals were infused with saline (15 ml:h −" :kg −" ) and later culled and hepatic tissue removed (non-septic Although ICI 118551 has been used in many studies it was necessary to have a non-infected control group to check for toxicity. These three groups of animals did not have a laparotomy performed for the reasons mentioned earlier and it was unnecessary to measure the haemodynamics.
Twenty animals had additional catheters inserted ; into the descending aorta via the femoral artery for blood sampling and arterial blood pressure monitoring. A balloon-tipped thermodilution catheter was inserted into the femoral vein and advanced into the pulmonary artery under pressure control to measure pulmonary artery occlusion pressure (PAOP), right atrial pressure and cardiac output. A midline laparotomy was performed and an ultrasound flow probe was placed around the hepatic portal vein. In 15 animals an incision was made in the caecum, 35 ml of the contents was aspirated and the incision closed. During the course of surgery, saline was infused (approximately 12-15 ml:min −" :kg −" ) to maintain normal physiological parameters.
When surgery was completed in all animals anaesthesia was changed to ketamine (5 mg\kg) and xylazine (1 mg\kg), and mechanical ventilation initiated with the FiO These twenty animals were divided into four groups. One group was kept non-septic and methoxamine infused (non-septic methoxamine group) to establish histological changes associated with the infusion of this specific α " agonist. Unlike the other control animals this group was instrumented to maintain blood flow, especially portal blood flow, at or above basal levels because of the real danger of splanchnic and hepatic hypoxia when using this vasoactive drug. In the other three groups sepsis was induced by spreading the caecal aspirant into the peritoneum. The other three groups were divided into the septic group where only saline was infused, the septic methoxamine group and the septic ICI 118551 group. All methoxamine-treated animals received 80 mg\h and all ICI 118551-treated animals received a bolus of 200 mg\kg followed by a similar hourly infusion.
Colloid in the form of hydroxyethyl starch was infused to maintain the PAOP at 10-12 mmHg in the septic and septicjICI 118551 groups. In the methoxamine-treated animals colloid infusion was adjusted to maintain portal blood flow above the basal value of 650 ml\min. The concentration of drug infused was also reduced periodically to maintain haemodynamic parameters when fluid adjustment alone would not suffice. Methoxamine infusion caused initial vasoconstriction but after an hour in the septic group this effect was considerably reduced and did not represent a problem. Haemodynamic parameters were measured hourly. After 8 h of study tissue core samples 2 mm in diameter were taken from at least 10 different areas of the liver using a BARD Biopsy-Cut fitted with a 14G biopsy needle (Bard Limited, Crawley, Sussex, UK.) and fixed in 3 % glutaraldehyde in cacodylate buffer. The animals were then culled. Haemodynamic parameters at 8 h only are presented for the sake of clarity. All the hourly data for each parameter during the study are available.
Systemic, right atrial and pulmonary artery occlusion pressures were recorded on an Ormed polygraph (Lectromed, Jersey, U.K.) using disposable transducers (Baxter Healthcare). These transducers were electrically calibrated at the beginning of the study and then hourly for its duration. A thermodilution computer (Edward's Laboratories, California, U.S.A.) was used to measure cardiac output by calculating the mean of three injections of 10 ml of iced physiological saline injected randomly during the respiration cycle. Portal vein blood flow was measured using an ultrasound flow probe (Transonic Systems, Ithaca, NY, U.S.A.). The flow probe was calibrated by passing blood at known flow rates through an excised blood vessel. Zero values were established by clamping the vessels for a short period at the beginning of the study and checked at the end. Blood gas analysis was performed on arterial blood using a 1306 IL machine (Instruments Laboratory, Milan, Italy). The 1306 IL blood gas analyser was calibrated with each set of measurements. Standard formulae were used to calculate systemic vascular resistance.
Hepatic tissue was post-fixed in buffered 1 % osmium tetroxide, dehydrated through ascending concentrations of ethanol and embedded in Spurr's resin. Semi-thin resin sections (2 µm) of hepatic tissue were prepared for light microscopy, mounted on glass slides, coded and randomized so that the observer was unaware of the study groups. They were viewed using a light microscope and video monitor at a magnification of 800 ; 10 consecutive areas on each slide were captured and digitized by pixel counting, using the N.I.H. image analysis programme (public domain freeware). The areas digitized were : endothelial area (area occupied by endothelium), perisinusoidal area (the area between the endothelium and hepatocytes), vacuolation area (area of open membranebound cytosolic vacuoles within hepatocyte cells). A leucocyte count per sinusoid was taken.
Statistical analysis
Haemodynamic data were analysed by single-factor analysis of variance after 8 h of infection to compare differences among the groups at the time hepatic tissue was taken. Morphometric data were not normally distributed and a logarithmic transformation was performed. The data were analysed by single-factor analysis of variance. All tests were two-tailed with a P 0.05 considered significant. Summary data are expressed as means and S.D.
RESULTS

Hepatic histology
The severity of the hepatic histological changes in this study can be seen in the micrographs of Figure 1 . Hepatic tissue taken from the control group showed patent sinusoids lined by a thin endothelium overlaying a distinct narrow perisinusoidal Space of Disse and the apical microvillus hepatocyte surface. Within the sinusoid lumen were free-flowing erythrocytes, lymphocytes and neutrophils. The hepatocytes were normal, containing within their cytoplasm distinct mitochondria and both rough and smooth endoplasmic reticulum.
Tissue taken from the septic group showed deranged morphology. In the sinusoid lumen there were occlusive plugs of lymphocytes, polymorphonuclear leucocytes, platelets, cellular debris, membranous ghosts and occlusive spherical erythrocytes. Both the swollen endothelium and activated Kupffer cells bulged into the sinusoid and often occluded the sinusoid lumen appearing to trap platelets and leucocytes. Singlemembrane-bound vacuoles containing granuloreticular material were visible in both endothelial and Kupffer cells. The perisinusoidal Space of Disse was either indistinct or absent as the swollen endothelium or trapped luminal leucocytes flattened the hepatocyte apical microvilli. The hepatocytes showed swollen, granular indistinct mitochondria and both normal and dilated irregular forms of endoplasmic reticulum. There was the occasional presence of single-membrane-bound vacuoles in the cytoplasm. The platelets were activated and had many pseudopods.
In tissue taken from the septic ICI 118551 group the sinusoid lumen contained lymphocytes, polymorphonuclear leucocytes, platelets and spherical erythrocytes. Adrenoceptor agonist and antagonist in sepsis The sinusoids were lined by an irregular endothelium with enlarged Space of Disse. The enlarged perisinusoidal area contained extravasated erythrocytes and cell debris. The apical membrane of the hepatocytes was frequently disrupted with their contents spilling into the perisinusoidal space. The surrounding hepatocytes contained swollen mitochondria and dilated rough endoplasmic reticulum. They were often separated from their neighbouring hepatocytes downwards from the apical surface. In hepatic tissue taken from the septic methoxamine group the sinusoidal endothelium showed some areas of swelling but maintained its integrity. The lumen contained many erythrocytes, leucocytes and platelets appearing to flow normally. The perisinusoidal Space of Disse was enlarged, separating it from the frequently damaged apical hepatocyte surface where the plasma membrane was often ruptured allowing cell contents to spill into the perisinusoidal area. Hepatocytes were often separated from each other and contained in the cytoplasm along with swollen mitochondria, many singlemembrane-bound vacuoles containing granular material.
Morphometric analysis of the ultrastructure of hepatic tissue
The numerical and statistical changes are presented in Table 2 . Leucocyte numbers in all the non-septic groups were similar to the control group. The septic and septicjICI 118551 groups had significantly higher numbers than all the other groups including septic methoxamine. Methoxamine infusion was associated with an attenuation of hepatic leucostasis during sepsis. Leucocyte numbers in the septic methoxamine group were significantly higher than in control, non-septic or non-septic ICI groups but not the non-septic methoxamine group.
Endothelial area in the control group was significantly lower than both uninfected groups (non-septic methoxamine or non-septic ICI 118551) and the three infected Adrenoceptor agonist and antagonist in sepsis Endothelial area in the septic group was significantly higher than in all the non-septic groups except non-septic ICI 118551. Neither methoxamine nor ICI 118551 had any effect on endothelial area during sepsis. Perisinusoidal area in all the non-septic groups was similar and significantly lower than either septic methoxamine or septic ICI 118551. The septic group values were significantly higher than those in the control or nonseptic groups but significantly lower than in the septic methoxamine or septic ICI 118551 groups. Values in the septic methoxamine and septic ICI 118551 groups were similar and significantly higher than in all the other groups. Both of these agents caused a separation of endothelium from the hepatocytes and the hepatocytes from each other.
Hepatocyte vacuolation was similar and at a very low level in the control, non-septic, non-septic ICI 118551 and septic ICI 118551 groups, but levels in the non-septic methoxamine group and the septic group were significantly higher than in either the control group or the nonseptic group. The septic group and non-septic methoxamine groups had significantly less hepatocyte vacuolation than the septic methoxamine group. The septic ICI 118551 group had significantly less vacuolation than either of the two methoxamine-treated groups. Hepatocyte vacuolation in the septic methoxamine group was significantly higher than in all the other groups.
Haemodynamics
Haemodynamic data were recorded after 8 h of sepsis at the time hepatic tissue was removed for ultrastructural analysis and are presented in Table 3 . The mean arterial pressure in the non-septic methoxamine group was significantly higher than either the septic or septic ICI groups. In the septic methoxamine group mean arterial pressure was not different to any of the other groups. It is important to stress that although the mean arterial pressure in the non-septic methoxamine group was significantly higher than in the septic group, mean arterial pressure in the septic methoxamine group was not different to that in the septic group. The septic animals were becoming refractory to the vasoactive effect of the drug. The PAOP in the non-septic methoxamine and septic methoxamine groups was significantly higher than in the septic or septic ICI 118551 groups. The PAOP in the septic methoxamine group was also significantly higher than in the non-septic methoxamine group. The cardiac output in the septic ICI 118551 group was significantly higher than in the septic group ; otherwise it was similar in all the other groups where it was recorded. In the septic methoxamine group the combination of a significantly higher PAOP without an increase in cardiac output is suggestive of heart failure induced by methoxamine. The stroke volume in the septic ICI 118551 group was significantly higher than in the septic, non-septic methoxamine or septic methoxamine groups. The systemic vascular resistance in the non-septic methoxamine group was significantly higher than in the septic ICI 118551 group ; otherwise there was little difference in this parameter among the other groups. Sepsis has a profound effect on reducing stroke volume resistance that was not antagonized by the vasoactive effect characteristic of methoxamine. Portal blood flow in the septic ICI 118551 group was significantly higher than in the septic group. There were no significant differences in heart rate or fluid administration in any of the groups.
DISCUSSION
The data in this study address the question of whether an α " adrenergic receptor agonist or a β # adrenergic receptor antagonist are pro-inflammatory when administered during sepsis. The question was examined by morphometric analysis of the hepatic changes seen in a septic porcine model of organ damage. In sepsis both agents were found to increase hepatic injury to tissue elements not normally observed in sepsis alone. The α " adrenergic receptor agonist also has detrimental effects on myocardial performance during sepsis, causing considerable heart failure.
The question was identified as important when it was found [5] that during sepsis, although hepatic blood flow was maintained 30 % above the basal level, dobutamine infusion was associated with increased hepatic injury, but when dopexamine was infused hepatic injury was less than that observed in sepsis alone. We described in the introduction one of the differences between dopexamine and dobutamine, which is the α " adrenergic receptor agonist of dobutamine ; both dopexamine and dobutamine are adrenergic β agonists. It is well established that β # adrenergic receptor agonists induce an anti-inflammatory response when an organism is challenged with pro-inflammatory agents [14] . When an endothelial monolayer, isolated organ or a whole animal are challenged with inflammatory mediators such as histamine, thrombin, leukotrienes or bradykinin, adrenergic β # agonists such as salbutamol or isoprenaline attenuate the inflammatory response. It was likely that β # adrenergic receptor stimulation was the characteristic of dopexamine that rendered it anti-inflammatory in our study. It is assumed that adrenergic β # agonists stimulate a pre-existing endogenous anti-inflammatory cellular response initiated by cell-surface receptor activation and membrane transduction to inhibit or control the cytosolic pathway of inflammatory mediator production. There seemed little point in duplicating the earlier work demonstrating the anti-inflammatory characteristics of these agents. Blockade of the supposed endogenous β # adrenergic receptor-stimulated anti-inflammatory cellular response had not been reported previously.
Methoxamine is a specific α1 adrenergic receptor agonist whereas ICI 118551 is a specific β # adrenergic receptor antagonist. A detailed morphometric analysis of hepatic components and their changes in sepsis with methoxamine or ICI 118551 was made, and the results compared with septic and non-septic hepatic tissue samples taken from our pig model both with and without these adrenergic receptor agents.
In this animal study there was considerable deterioration in hepatic ultrastructure in septic animals. However, in those septic animals infused with either ICI 118551 or methoxamine there was further significant deterioration. There were significant differences in the hepatic ultrastructure in the four groups of animals but the portal blood flow measured in the septic groups or the non-septic methoxamine group was either similar to baseline values or higher. There was no correlation between the reported portal blood flow and changes in the hepatic ultrastructure ; portal blood flow measured in this study did not seem to be an important parameter in determining changes in the hepatic ultrastructural elements.
Deterioration in perivascular elements was similar when the two agents being investigated were infused.
Administration of the β # adrenergic receptor antagonist or the α " adrenergic receptor agonist during sepsis was associated with considerable deterioration in hepatocyte\hepatocyte and hepatocyte\endothelial adhesion. Some hepatocytes had damage to their apical membrane but damage to the plasma membrane separating the hepatocytes was not seen. This finding suggests that the hepatocytes had lost their ability to adhere to each other either because their binding site was blocked or, more likely, the cytosolic production of adhesion Adrenoceptor agonist and antagonist in sepsis Scheme 1 Inflammatory cell transduction pathway initiated by α 1 adrenoceptor agonist PLC, phospholipase C ; IP3, inositol trisphosphate ; DAG, diacylglycerol ; PLA2c, cytosolic phospholipase A2 ; LTB, leukotriene ; TBX, thromboxane ; PAF, platelet-activating factor ; MAP kinase, mitogen-activated protein kinase ; NF-κB, nuclear factor κB ; Iκ-B, NF-κB inhibitor.
molecules especially the cadherins [17] was inhibited. In the septic methoxamine-treated animals it is possible that the production of all types of adhesion molecules had been inhibited as demonstrated by the significant lack of sinusoidal leucostasis.
In the septic methoxamine group but not in the septic ICI 118551 group, significant hepatocyte vacuolation was observed. The hepatocytes showed a substantial number of membrane-lined vacuoles, giving the microscopic sections of the liver an appearance of ' Swiss cheese '. These changes represent a substantial deterioration of the hepatic ultrastructure compared with the sepsis group.
Methoxamine is an α " adrenergic receptor agonist with no record of cellular damage when blood flow is maintained. α " adrenergic receptor agonists are not normally associated with inflammatory changes in physiological preparations but do have characteristics in common with inflammatory mediators such as thrombin, bradykinin and leukotrienes. Although they all activate their own cell-surface receptors, their cell response is achieved by the stimulation of the common trimeric G-protein complex [12, 18] and formation of the cell membrane transmitter Gq described in Scheme 1. Gq activates phospholipase C which increases diacylglycerol and inositol triphosphate ; intracellular calcium concentration is raised by the formation of inositol triphosphate [14] and inflammatory lipids are produced by the action of diacylglycerol and the activation of calcium-dependent cytosolic phospholipase A2. Diacylglycerol also activates protein kinase C that phosphorylates nuclear factor-κB inhibitor, releasing nuclear factor-κB. Inflammatory peptides such as cytokines are produced by the activation of the gene transcription factors mitogen-activated protein kinase and nuclear factor-κB. Activation of Gq is intimately involved in the activation of the inflammatory process, increasing cytosolic calcium, and the production of both inflammatory lipids and peptides. α
"
Adrenergic receptor agonists such as methoxamine are known to cause constriction of smooth muscle and precipitate vasoconstriction by raising intracellular calcium. A similar system is also present in endothelial cells when the actin\myosin cytoskeleton is activated to cause cell contraction and increase capillary permeability. When inositol triphosphate is released into the cytosol it increases the permeability of endoplasmic reticulum and the plasma membrane to calcium allowing its rapid influx into the cell. This increase in cytosolic calcium, although physiological, is associated with major changes in cellular activity depending on the cell type. High levels of calcium in the cytosol are toxic to the cell and quickly cause its death. The uptake of calcium by the mitochondria, used as a ' sink ' to reduce calcium levels, is associated with uncoupling of respiration and irreversible destruction [19] . Raised cytosolic calcium is important in many of the steps of the signal transduction cascade activated by the pro-inflammatory mediators mentioned earlier to produce inflammatory lipids and peptides. The hepatocyte vacuoles that we have described may contain calcium and represent an attempt by the cell to reduce cytosolic calcium concentration. This is the first report showing that the characteristics of a drug are radically changed when there is a major inflammatory response to tissue injury. We have previously reported that dobutamine infusion during sepsis is associated with major hepatic injury similar to the changes seen in the methoxamine-treated animals. It is highly likely that the α " adrenergic receptor agonist properties of dobutamine cause the hepatic injury when infused during sepsis. A recent publication by Le Tulzo et al. has shown the importance of α adrenergic receptor blockade in reducing the inflammatory response to tissue injury [20] . Phentolamine administration in haemorrhagic mice prevented the rise in mRNA level of interleukin (IL)-1, tumour necrosis factor and the activation of the gene transcription factor nuclear factor-κB normally seen with this haemorrhagic animal model. Propranolol pretreatment caused an increase in these factors, greater than haemorrhage alone, that might be associated with greater deterioration of organ function in this animal model.
We have previously shown [5] that hepatic ultrastructural protection is produced by dopexamine associated with its β # adrenergic receptor agonist properties. It seems likely that there is an endogenous anti-inflammatory response to sepsis mediated by β # adrenoceptor agonists on the cell surface that can be inhibited by ICI 118551. Amplification of hepatic injury in these septic animals treated with ICI 118551 confirms the presence of a β # adrenergic receptor-mediated endogenous antiinflammatory response to tissue injury.
There is considerable research documentation reporting that β # adrenergic receptor agonists reduce the tissue response to inflammatory mediators by both reducing capillary permeability and inhibiting the production of further inflammatory mediators. Several reports describe how a second messenger of membrane transduction cAMP or protein kinase A, activated when Gs is formed from β # adrenergic receptor activation, inhibits the activation of phospholipase C and the gene transcription factor mitogen-activated protein kinase (see Scheme 2) . Inhibition of membrane-bound phospholipase C reduces the production of inflammatory lipids and the transcription of inflammatory peptides [21] .
Szabo et al. [22] described how pretreatment of rats with isoproterenol blunted the lipopolysaccharideinduced increase in tumour necrosis factor and nitric oxide production but increased the IL-10 response (an anti-inflammatory cytokine). In a model of inflammation [23] bradykinin infusion was used to stimulate the intracellular production of phospholipase C, inositol trisphosphate, diacylglycerol and arachidonic acid. Arginine vasopressin, forskolin and isobutylmethylxanthine were infused to increase cAMP levels and stimulate protein kinase A production. An increased cellular concentration of protein kinase A was associated with an inhibition of the inflammatory response to bradykinin with a reduction of the transmembrane mediators of inflammation, especially phospholipase C, inositol trisphosphate and diacylglycerol.
We have recently reviewed [14] the importance of β # adrenergic receptor agonists during the inflammatory response to sepsis and the mechanism of cell protection. The cytokine IL-10 is produced during the inflammatory processes, usually by the same cells that release inflammatory cytokines. It is a potent anti-inflammatory molecule which inhibits the synthesis of pro-inflammatory cytokines (tumour necrosis factor, IL-1, IL-6 and IL-8) by monocytes, macrophages [24] , neutrophils [25] and eosinophils [26] . Interleukin-10 suppresses free oxygen radical release and nitric oxide-dependent microbicidal activity of macrophages as well as their production Adrenoceptor agonist and antagonist in sepsis Scheme 2 Endogenous anti-inflammatory cell transduction pathway initiated by β 2 adrenoceptor agonists CRE, cyclic AMP response element ; IL-10, interleukin 10.
of prostaglandins [27] [28] [29] [30] . It inhibits the production of these inflammatory cytokines by a negative-feedback mechanism. Endogenous production of IL-10 can be increased by several pharmacological compounds which elevate intracellular cAMP [31] . There appears to be a promoter sequence on the IL-10 gene [32] to the cAMP response element (CRE) that binds to the gene transcription factor CRE binding factor (CREB). β # Agonists have recently been shown to increase production of IL-10 from monocytes challenged with endotoxin [33] .
The clinical significance of these findings is that, in septic patients, α " adrenergic receptor agonists such as noradrenaline or dobutamine, used to stimulate cardiovascular function and tissue perfusion as well as maintain arterial blood pressure in hypotensive patients, may cause hepatic dysfunction and increase mortality in an already high-risk group of patients. These findings may explain the high mortality that is seen in septic patients with end-organ failure who exhibit significant hepatic dysfunction. β # Adrenergic receptor agonists activate the endothelial cell transduction process to initiate an endogenous antiinflammatory response in sepsis [14] that can be significantly attenuated by the β # adrenergic receptor antagonist ICI 118551. ICI 118551 is associated with an amplification of the inflammatory response when infused during sepsis. This paper also presents evidence that endogenous β # adrenergic receptor agonists produce an anti-inflammatory response and may give some protection against the tissue injury associated with severe inflammation caused by sepsis. The α " agonists can amplify the inflammatory response to sepsis even when blood flow is maintained. These data provide evidence that adrenergic receptor agonists are important in modifying the cellular response to inflammation, sepsis or the systemic inflammatory response syndrome.
